| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 196 | 6,931,058 | AVGO, C, CME, T | 13F-HR | 2/8/2024 | 000114036124006267 |
| Q3 2023 | 196 | 6,083,624 | AVGO, CME, PFE, JPM | 13F-HR | 11/13/2023 | 000156761923007682 |
| Q2 2023 | 184 | 6,171,217 | AVGO, CME, PFE, JPM | 13F-HR | 8/8/2023 | 000156761923006838 |
| Q1 2023 | 185 | 6,052,274 | AVGO, CME, PFE, JPM | 13F-HR | 5/9/2023 | 000156761923005950 |
| Q4 2022 | 201 | 5,914,564 | PFE, AVGO, CME, JPM | 13F-HR | 2/7/2023 | 000156761923002016 |
| Q3 2022 | 200 | 5,645,891 | CME, PFE, AVGO, RF | 13F-HR | 11/14/2022 | 000156761922020170 |
| Q2 2022 | 201 | 6,529,757 | CME, ABBV, AVGO, PFE | 13F-HR | 8/5/2022 | 000156761922015022 |
| Q1 2022 | 196 | 7,631,993 | CME, AVGO, ABBV, PFE | 13F-HR | 5/11/2022 | 000156761922010109 |
| Q4 2021 | 208 | 8,528,684 | AVGO, CME, ABBV, QCOM | 13F-HR | 2/10/2022 | 000156761922003269 |
| Q3 2021 | 209 | 8,145,878 | CME, AVGO, ABBV, JPM | 13F-HR | 11/9/2021 | 000156761921019598 |
| Q2 2021 | 1 | 9,008 | GTES | NEW HOLDINGS | 10/12/2021 | 000156761921018207 |
| Q2 2021 | 205 | 8,686,996 | CME, JPM, ABBV, AVGO | 13F-HR | 8/10/2021 | 000156761921014957 |
| Q1 2021 | 207 | 8,615,564 | JPM, CME, ABBV, AVGO | 13F-HR | 5/14/2021 | 000156761921010156 |
| Q4 2020 | 227 | 8,426,616 | CME, JPM, AVGO, ABBV | 13F-HR | 2/9/2021 | 000156761921002566 |
| Q3 2020 | 164 | 7,564,599 | BABA, JPM, CME, ABBV | 13F-HR | 11/5/2020 | 000156761920018725 |
| Q2 2020 | 159 | 7,787,930 | ABBV, BABA, JPM, CME | 13F-HR | 8/7/2020 | 000156761920014505 |
| Q1 2020 | 163 | 6,992,768 | BABA, CME, JPM, WBA | 13F-HR | 5/13/2020 | 000156761920009724 |
| Q4 2019 | 171 | 10,397,123 | CME, JPM, RDS.A, BABA | 13F-HR | 2/10/2020 | 000156761920002463 |
| Q3 2019 | 170 | 10,368,607 | CME, JPM, RDS.A, BABA | 13F-HR | 11/12/2019 | 000156761919020981 |
| Q2 2019 | 170 | 10,421,323 | CME, RDS.A, JPM, BABA | 13F-HR | 8/6/2019 | 000156761919015833 |
| Q1 2019 | 175 | 10,336,235 | RDS.A, CME, JPM, BABA | 13F-HR | 5/7/2019 | 000156761919010002 |
| Q4 2018 | 171 | 10,219,371 | CME, RDS.A, JPM, WBA | 13F-HR | 2/6/2019 | 000156761919002522 |
| Q3 2018 | 161 | 11,985,338 | RDS.A, CME, JPM, WBA | 13F-HR | 11/2/2018 | 000156761918004971 |
| Q2 2018 | 227 | 13,157,384 | RDS.A, CME, JPM, WBA | 13F-HR | 8/14/2018 | 000156761918000760 |
| Q1 2018 | 231 | 13,259,976 | RDS.A, CME, JPM, WBA | 13F-HR | 5/7/2018 | 000114036118021873 |
| Q4 2017 | 243 | 14,381,867 | JPM, CME, RDS.A, HD | 13F-HR | 2/14/2018 | 000114036118007591 |
| Q3 2017 | 243 | 14,002,536 | JPM, CME, RDS.A, HD | 13F-HR | 11/13/2017 | 000114036117041962 |
| Q2 2017 | 249 | 13,143,252 | JPM, CME, RDS.A, HD | 13F-HR | 8/14/2017 | 000114036117031572 |
| Q1 2017 | 265 | 12,305,694 | JPM, CME, RDS.A, HD | 13F-HR | 5/9/2017 | 000114036117018981 |
| Q4 2016 | 274 | 12,960,213 | JPM, CME, RDS.A, HD | 13F-HR | 2/10/2017 | 000114036117005698 |
| Q3 2016 | 254 | 13,130,401 | JPM, CME, RDS.A, AGN | 13F-HR | 11/14/2016 | 000114036116086002 |
| Q2 2016 | 260 | 12,919,157 | JPM, RDS.A, CME, AGN | 13F-HR | 8/12/2016 | 000114036116076089 |
| Q1 2016 | 264 | 14,997,571 | JPM, CME, HD, T | 13F-HR | 5/12/2016 | 000114036116064713 |
| Q4 2015 | 293 | 15,743,180 | CME, JPM, HD, T | 13F-HR | 2/9/2016 | 000114036116050791 |
| Q3 2015 | 276 | 15,943,872 | CME, JPM, HD, T | 13F-HR | 11/12/2015 | 000114036115040685 |
| Q2 2015 | 306 | 17,364,219 | CME, JPM, RDS.A, HD | 13F-HR | 8/12/2015 | 000114036115031209 |
| Q1 2015 | 307 | 17,971,360 | JPM, CME, RDS.A, NXPI | 13F-HR | 5/13/2015 | 000114036115019289 |
| Q4 2014 | 304 | 19,993,658 | JPM, RDS.A, LBTYK, BIDU | 13F-HR | 2/11/2015 | 000114036115005321 |
| Q3 2014 | 313 | 22,160,693 | JPM, BIDU, ACTAVIS PLC, LBTYK | 13F-HR | 11/12/2014 | 000114036114041143 |
| Q2 2014 | 320 | 25,072,636 | SLB, BIDU, TSM, JPM | RESTATEMENT | 8/11/2014 | 000114036114031708 |
| Q1 2014 | 294 | 25,403,775 | SLB, BIDU, YUM, ACN | 13F-HR | 5/14/2014 | 000114036114020942 |
| Q4 2013 | 285 | 26,203,978 | BIDU, SLB, YUM, YNDX | 13F-HR | 2/13/2014 | 000114036114006829 |